A 25 Week, Open Label Study to Determine the Effects of Nebivolol When Added to Hydrochlorothiazide on Diastolic Function and Arterial Stiffness in African Americans With Hypertension.
Phase of Trial: Phase II
Latest Information Update: 04 May 2011
At a glance
- Drugs Hydrochlorothiazide; Nebivolol
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms NASAA
- Sponsors InVasc Therapeutics
- 06 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Nov 2009 New trial record